LEN vs VREX · rev $34.19B vs rev $844.6M
LEN (LEN) versus Varex Imaging Corp (VREX) — a side-by-side from cached financials, not a winner call.
LEN (LEN) common stock.
Varex Imaging Corp (VREX) is a medical devices company listed on US.
Latest reported LEN revenue for 2025-11-30 was $34.19B. Net income was $2.08B. Revenue was down 3.5% from 2024-11-30 to 2025-11-30. LEN currently screens at market cap $0.
Latest reported VREX revenue for 2025-10-03 was $844.6M. Net income was -$69.9M. Revenue was up 4.1% from 2024-09-27 to 2025-10-03. VREX currently screens at market cap $350.0M.
LEN currently screens at market cap $0. VREX currently screens at market cap $350.0M.
Not investment advice. Open the LEN and VREX stock pages for the full models.
Not investment advice.